Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4780737> ?p ?o }
Showing triples 1 to 24 of
24
with 100 triples per page.
- Q4780737 subject Q6994987.
- Q4780737 subject Q6995402.
- Q4780737 subject Q6995494.
- Q4780737 subject Q8518215.
- Q4780737 abstract "Apotex Inc v Wellcome Foundation Ltd, [2002] 4 S.C.R. 153, is a leading Supreme Court of Canada decision on the utility requirement for a patent in Canada. The Court rejected a challenge by the generic drug manufacturers Novopharm and Apotex to declare Glaxo Wellcome's patent for AZT, an AIDS-fighting drug, invalid.".
- Q4780737 wikiPageExternalLink 2001fc27625.shtml.
- Q4780737 wikiPageWikiLink Q12199.
- Q4780737 wikiPageWikiLink Q196615.
- Q4780737 wikiPageWikiLink Q198504.
- Q4780737 wikiPageWikiLink Q212322.
- Q4780737 wikiPageWikiLink Q253623.
- Q4780737 wikiPageWikiLink Q3000992.
- Q4780737 wikiPageWikiLink Q390551.
- Q4780737 wikiPageWikiLink Q4780735.
- Q4780737 wikiPageWikiLink Q6598722.
- Q4780737 wikiPageWikiLink Q6994987.
- Q4780737 wikiPageWikiLink Q6995402.
- Q4780737 wikiPageWikiLink Q6995494.
- Q4780737 wikiPageWikiLink Q7707112.
- Q4780737 wikiPageWikiLink Q7902830.
- Q4780737 wikiPageWikiLink Q7902844.
- Q4780737 wikiPageWikiLink Q8518215.
- Q4780737 comment "Apotex Inc v Wellcome Foundation Ltd, [2002] 4 S.C.R. 153, is a leading Supreme Court of Canada decision on the utility requirement for a patent in Canada. The Court rejected a challenge by the generic drug manufacturers Novopharm and Apotex to declare Glaxo Wellcome's patent for AZT, an AIDS-fighting drug, invalid.".
- Q4780737 label "Apotex Inc v Wellcome Foundation Ltd".